CPT® Code 80416

The CPT® Code 80416 refers to a specialized laboratory test known as the renal vein renin stimulation panel, which is utilized primarily for diagnosing renovascular hypertension. This condition may arise from renal artery stenosis (RAS), characterized by a narrowing of the renal blood vessels, often due to the buildup of atherosclerotic plaque or fibromuscular hyperplasia. In cases where hypertension is attributed to RAS, treatment options may include the use of angiotensin-converting enzyme (ACE) inhibitors, which can help manage blood pressure. The renal vein renin stimulation test is critical in assessing the baseline renin levels produced by the kidneys and observing the changes that occur after administering an ACE inhibitor, specifically captopril. To ensure accurate results, patients are required to discontinue any diuretics and ACE inhibitors at least 14 days prior to the test and maintain a normal sodium diet, typically ranging from 100 to 200 mEq per day for three days leading up to the procedure. The test involves catheterization of the renal veins, which can be accessed via a transfemoral or jugular approach using a specific type of catheter. During the procedure, small amounts of contrast material are injected to verify the correct positioning of the catheter. Blood samples are collected from both the right and left renal veins to measure renin levels before and after the administration of captopril, which is given in doses of 25 to 50 mg. Subsequent blood samples are taken at designated intervals to monitor the changes in renin levels, with serum or plasma analyzed through quantitative immunoradiometry techniques.